fashion -WSS

fashion

author：explore 2025-09-30 23:07:25 - browse：5

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Radiation, mainstay of cancer treatment, begins a fade

entertainment

WSS

Neuroscience startup Neumora files for IPO

Apellis safety probe of eye disease drug centers on injection needle

In science, is the line between industry and academia shifting?

Study: Hearing aids may slow cognitive decline in those at risk

Neuroscience startup Neumora files for IPO

FDA seeking to stop procedures at two unregulated stem cell clinics

hotspot

fashion

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Appeals court upholds limits to abortion pill

Hollywood unions extend contract negotiations for actors

Winners, losers from Medicare’s list of drugs subject to price talks

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to make AI work for medicine

Medical leaders decry Supreme Court decision on affirmative action

How to make Best Hospitals ratings actually useful for patients

In age of alternative facts, a scholarly course on calling out crap

Robert Kennedy Jr.'s presidential campaign attracts GOP

focus

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

US soldier in North Korean custody after crossing DMZ line

Why you get paid to donate plasma but not blood

Psilocybin's anti

Drug firms test therapies to halt Alzheimer’s before symptoms arise

A Theranos scientist

hotspot

Wikipedia

entertainment

explore